Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.04 USD | +0.60% | +3.28% | +19.43% |
May. 08 | Transcript : Vanda Pharmaceuticals Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q1 Revenue $47.5M | MT |
Financials (USD)
Sales 2024 * | 194M | Sales 2025 * | 232M | Capitalization | 293M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | -19M | EV / Sales 2024 * | 0.54 x |
Net cash position 2024 * | 189M | Net Debt 2025 * | 65.1M | EV / Sales 2025 * | 1.54 x |
P/E ratio 2024 * |
-84
x | P/E ratio 2025 * |
-15.3
x | Employees | 203 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.01% |
Latest transcript on Vanda Pharmaceuticals Inc.
1 day | +0.60% | ||
1 week | +3.28% | ||
Current month | +5.88% | ||
1 month | +17.76% | ||
3 months | +21.15% | ||
6 months | +47.80% | ||
Current year | +19.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 02-10-31 | |
Kevin Moran
DFI | Director of Finance/CFO | 40 | 12-11-30 |
Scott Howell
HRO | Human Resources Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard W. Dugan
BRD | Director/Board Member | 82 | 05-11-30 |
Chief Executive Officer | 64 | 02-10-31 | |
Director/Board Member | 72 | 20-02-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.34% | 0 M€ | -1.57% | ||
0.22% | 0 M€ | -2.98% | - | |
0.05% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 5.04 | +0.60% | 1,384,022 |
24-05-09 | 5.01 | -6.53% | 1,969,904 |
24-05-08 | 5.36 | -2.19% | 2,041,054 |
24-05-07 | 5.48 | +13.22% | 4,717,433 |
24-05-06 | 4.84 | -0.82% | 1,288,463 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.43% | 293M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- VNDA Stock